LICENSE AGREEMENTLicense Agreement • July 4th, 2017 • England and Wales
Contract Type FiledJuly 4th, 2017 JurisdictionWHEREAS, the Licensor has been granted by AbbVie Inc. and AbbVie Deutschland GmbH & Co KG (collectively, “AbbVie”) the right to sublicense certain patents and patent applications, which relate to the antiretroviral compounds known as lopinavir and ritonavir;